EAS Newsletter July 23, 2024

Society:

Don’t let this opportunity pass you by. Apply for an EAS Competitive grant

Don’t let this opportunity pass you by! Submit your application for an EAS Competitive grant by September 13, 2024. Before you apply, make sure to thoroughly review the eligibility criteria, funding terms, and conditions listed below. Take this chance to boost your career with EAS!

Education:

EAS-LatAm webinar series will continue. Be sure to register for the third webinar!

The atherogenic role of triglyceride-rich lipoproteins (TRL) and whether mild or moderate increases warrant pharmacological intervention have long been subjects of debate. Despite gaps in our understanding of the mechanisms behind residual risk, TRLs are thought to play a significant role. Improving our understanding of TRL’s effects on the atherosclerotic process is essential for advancing our management of hypertriglyceridemia.

Join us for the third webinar in our joint EAS-LatAm series to explore this topic in depth. Register now!

Education:

Enroll in the Certificate in Lipidology for Nurses and HCPs with a 50% EAS Member discount!

Are you a nurse or healthcare professional working in lipid clinics, eager to address atherosclerotic vascular disease challenges in your daily practice? Enroll in our new Lipidology Certificate for Nurses and Healthcare Professionals! EAS members receive a 50% discount on the regular price.

Share this opportunity with your clinic team and encourage them to enhance their skills and expand their knowledge.

Education:

The Certificate of Excellence in Lipidology 2023 Update: a must-have credential for your professional career

Ready to advance your career significantly? Enroll in this highly acclaimed program, praised by past participants. Clinicians often find managing atherosclerotic vascular disease challenging.

This initiative is designed to enhance the standard of clinical care for individuals dealing with cardiovascular disease or those focused on cardiovascular prevention.

Publications:

Recent issue highlights – May & June 2024

The May issue of Atherosclerosis contains several articles on the importance of imaging biomarkers in the diagnostics, prognostics, and monitoring of atherosclerotic cardiovascular diseases per se and as a reference for the evaluation of circulating biomarkers.

ApoB containing lipoproteins are a causal risk factor of atherosclerotic cardiovascular disease. This Newsletter summarizes several articles published in the June issue of Atherosclerosis that addressed novel questions to the interaction of plasma levels of apoB containing lipoproteins with other risk factors in the determination of cardiovascular risk or treatment effectiveness, the effectiveness of familial hypercholesterolemia (FH) screening, the treatment of homozygous FH, or novel targets for cholesterol lowering therapies.